Proposed Data Collection Submitted for Public Comment and Recommendations, 66987-66988 [2020-23248]
Download as PDF
66987
Federal Register / Vol. 85, No. 204 / Wednesday, October 21, 2020 / Notices
• Cognitive laboratory studies, such as
those used to refine questions or
assess usability of a website;
• Qualitative customer satisfaction
surveys (e.g., post-transaction
surveys; opt-out web surveys)
• In-person observation testing (e.g.,
website or software usability tests)
information collection to ensure
compliance with the terms of this
clearance prior to submitting each
collection to OMB. CDC requests
approval for an estimated 3,850 annual
burden hours. There are no costs to
respondents other than their time.
The Agency has established a
manager/managing entity to serve for
this generic clearance and will conduct
an independent review of each
ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hours)
Total burden
(in hours)
Form name
General public ...................................
Online surveys .................................
Focus groups ...................................
In-person surveys .............................
Usability testing ................................
Customer comment cards ................
1,500
800
1,000
1,500
1,000
1
1
1
1
1
30/60
2
30/60
30/60
15/60
750
1,600
500
750
250
Total ...........................................
...........................................................
........................
........................
........................
3,850
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–23247 Filed 10–20–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[60Day-21–0199; Docket No. CDC–2020–
0107]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Application for Permit to Import
Biological Agents and Vectors of Human
Disease into the United States,
Application for Permit to Import or
Transport Live Bats, and Application for
Permit to Import Infectious Human
Remains into the United States (OMB
Control No. 0920–0199). The purpose of
this data collection is to support Section
361 of the Public Health Service (PHS)
SUMMARY:
VerDate Sep<11>2014
16:58 Oct 20, 2020
Jkt 253001
Act and to prevent the introduction,
transmission, or spread of
communicable diseases from foreign
countries into the States or possessions,
or from one State or possession into any
other State or possession.
DATES: CDC must receive written
comments on or before December 21,
2020.
You may submit comments,
identified by Docket No. CDC–2020–
0199 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7118; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
ADDRESSES:
Centers for Disease Control and
Prevention
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
responses per
respondent
Number of
respondents
Type of respondents
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
Import regulations for infectious
biological agents, infectious substances,
and vectors (42 CFR 71.54) (OMB
Control No. 0920–0199, Exp. 4/30/
E:\FR\FM\21OCN1.SGM
21OCN1
66988
Federal Register / Vol. 85, No. 204 / Wednesday, October 21, 2020 / Notices
2021)—Revision—Center for
Preparedness and Response (CPR),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Section 361 of the Public Health
Service Act (42 U.S.C. 264), as
amended, authorizes the Secretary of
Health and Human Services to make
and enforce such regulations as are
necessary to prevent the introduction,
transmission, or spread of
communicable diseases from foreign
countries into the States or possessions,
or from one State or possession into any
other State or possession. Part 71 of
Title 42, Code of Federal Regulations
(Foreign Quarantine) sets forth
provisions to prevent the introduction,
transmission, and spread of
communicable disease from foreign
countries into the United States.
Subpart F—Importations—contains
provisions for the importation of
infectious biological agents, infectious
substances, and vectors (42 CFR 71.54);
requiring persons that import these
materials to obtain a permit issued by
the CDC.
The Application for Permit to Import
Biological Agents, Infectious Substances
and Vectors of Human Disease into the
United States form is used by laboratory
facilities, such as those operated by
isolation and containment information.
CDC does not plan to revise this
application.
government agencies, universities, and
research institutions to request a permit
for the importation of biological agents,
infectious substances, or vectors of
human disease. This form currently
requests applicant and sender contact
information; description of material for
importation; facility isolation and
containment information; and personnel
qualifications. CDC plans to revise this
application to:
(1) Remove question 10 ‘‘Will the
permittee be the courier of the imported
biological agent?’’ from Section A since
it is the same question found in section
C, question 1.
(2) Add example to section F,
question 2 for clarity to read,
‘‘Protective Clothing (e.g., laboratory
coat).’’
These revisions will not affect the
burden hours.
The Application for Permit to Import
or Transport Live Bats form is used by
laboratory facilities such as those
operated by government agencies,
universities, research institutions, and
for educational, exhibition, or scientific
purposes to request a permit for the
importation, and any subsequent
distribution after importation, of live
bats. This form currently requests the
applicant and sender contact
information; a description and intended
use of bats to be imported; and facility
The Application for Permit to Import
Infectious Human Remains into the
United States is used by facilities that
will bury/cremate the imported cadaver
and educational facilities to request a
permit for the importation and
subsequent transfers throughout the
U.S. of human remains or body parts
that contains biological agents,
infectious substances, or vectors of
human disease. This form will request
applicant and sender contact
information; facility processing human
remains; cause of death; biosafety and
containment information; and final
destination(s) of imported infectious
human remains. CDC does not plan to
revise this application.
Annualized burden hours were
calculated based on data obtained from
CDC import permit database on the
number of permits issued on annual
basis since 2015, which is 2,000
respondents. The total estimated burden
for the data collection is 1,098. There is
a decrease in burden from 1,355 hours
to 1,098 hours to reflect the
implementation of the Electronic Import
Permit Program portal (eIPP) which has
decreased the time required to enter
information.
ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hours)
Total burden
hours
Form name
Applicants Requesting to Import Biological Agents, Infectious Substances and Vectors.
2,000
1
30/60
1,000
380
1
10/60
63
Applicants Requesting to Import Live
Bats.
Applicants Requesting to Import Infectious Human Remains into the
United States.
Application for Permit to Import Biological Agents, Infectious Substances and Vectors of Human
Disease into the United States.
Application for Permit to Import Biological Agents, Infectious Substances and Vectors of Human
Disease into the United StatesSubsequent Transfer.
Application for a Permit to Import
Live Bats.
Application for Permit to Import Infectious Human Remains into the
United States.
3
1
20/60
1
100
1
20/60
33
Total ...........................................
...........................................................
........................
........................
........................
1,098
Applicants Requesting to Import Biological Agents, Infectious Substances and Vectors.
khammond on DSKJM1Z7X2PROD with NOTICES
Number
responses per
respondent
Number of
respondents
Type of respondent
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–23248 Filed 10–20–20; 8:45 am]
BILLING CODE 4163–18–P
VerDate Sep<11>2014
16:58 Oct 20, 2020
Jkt 253001
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
E:\FR\FM\21OCN1.SGM
21OCN1
Agencies
[Federal Register Volume 85, Number 204 (Wednesday, October 21, 2020)]
[Notices]
[Pages 66987-66988]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-23248]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-21-0199; Docket No. CDC-2020-0107]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled Application for Permit to Import
Biological Agents and Vectors of Human Disease into the United States,
Application for Permit to Import or Transport Live Bats, and
Application for Permit to Import Infectious Human Remains into the
United States (OMB Control No. 0920-0199). The purpose of this data
collection is to support Section 361 of the Public Health Service (PHS)
Act and to prevent the introduction, transmission, or spread of
communicable diseases from foreign countries into the States or
possessions, or from one State or possession into any other State or
possession.
DATES: CDC must receive written comments on or before December 21,
2020.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2020-
0199 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7118; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
5. Assess information collection costs.
Proposed Project
Import regulations for infectious biological agents, infectious
substances, and vectors (42 CFR 71.54) (OMB Control No. 0920-0199, Exp.
4/30/
[[Page 66988]]
2021)--Revision--Center for Preparedness and Response (CPR), Centers
for Disease Control and Prevention (CDC).
Background and Brief Description
Section 361 of the Public Health Service Act (42 U.S.C. 264), as
amended, authorizes the Secretary of Health and Human Services to make
and enforce such regulations as are necessary to prevent the
introduction, transmission, or spread of communicable diseases from
foreign countries into the States or possessions, or from one State or
possession into any other State or possession. Part 71 of Title 42,
Code of Federal Regulations (Foreign Quarantine) sets forth provisions
to prevent the introduction, transmission, and spread of communicable
disease from foreign countries into the United States. Subpart F--
Importations--contains provisions for the importation of infectious
biological agents, infectious substances, and vectors (42 CFR 71.54);
requiring persons that import these materials to obtain a permit issued
by the CDC.
The Application for Permit to Import Biological Agents, Infectious
Substances and Vectors of Human Disease into the United States form is
used by laboratory facilities, such as those operated by government
agencies, universities, and research institutions to request a permit
for the importation of biological agents, infectious substances, or
vectors of human disease. This form currently requests applicant and
sender contact information; description of material for importation;
facility isolation and containment information; and personnel
qualifications. CDC plans to revise this application to:
(1) Remove question 10 ``Will the permittee be the courier of the
imported biological agent?'' from Section A since it is the same
question found in section C, question 1.
(2) Add example to section F, question 2 for clarity to read,
``Protective Clothing (e.g., laboratory coat).''
These revisions will not affect the burden hours.
The Application for Permit to Import or Transport Live Bats form is
used by laboratory facilities such as those operated by government
agencies, universities, research institutions, and for educational,
exhibition, or scientific purposes to request a permit for the
importation, and any subsequent distribution after importation, of live
bats. This form currently requests the applicant and sender contact
information; a description and intended use of bats to be imported; and
facility isolation and containment information. CDC does not plan to
revise this application.
The Application for Permit to Import Infectious Human Remains into
the United States is used by facilities that will bury/cremate the
imported cadaver and educational facilities to request a permit for the
importation and subsequent transfers throughout the U.S. of human
remains or body parts that contains biological agents, infectious
substances, or vectors of human disease. This form will request
applicant and sender contact information; facility processing human
remains; cause of death; biosafety and containment information; and
final destination(s) of imported infectious human remains. CDC does not
plan to revise this application.
Annualized burden hours were calculated based on data obtained from
CDC import permit database on the number of permits issued on annual
basis since 2015, which is 2,000 respondents. The total estimated
burden for the data collection is 1,098. There is a decrease in burden
from 1,355 hours to 1,098 hours to reflect the implementation of the
Electronic Import Permit Program portal (eIPP) which has decreased the
time required to enter information.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number burden per Total burden
Type of respondent Form name respondents responses per response (in hours
respondent hours)
----------------------------------------------------------------------------------------------------------------
Applicants Requesting to Application for 2,000 1 30/60 1,000
Import Biological Agents, Permit to
Infectious Substances and Import
Vectors. Biological
Agents,
Infectious
Substances and
Vectors of
Human Disease
into the United
States.
Applicants Requesting to Application for 380 1 10/60 63
Import Biological Agents, Permit to
Infectious Substances and Import
Vectors. Biological
Agents,
Infectious
Substances and
Vectors of
Human Disease
into the United
States-
Subsequent
Transfer.
Applicants Requesting to Application for 3 1 20/60 1
Import Live Bats. a Permit to
Import Live
Bats.
Applicants Requesting to Application for 100 1 20/60 33
Import Infectious Human Permit to
Remains into the United Import
States. Infectious
Human Remains
into the United
States.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 1,098
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2020-23248 Filed 10-20-20; 8:45 am]
BILLING CODE 4163-18-P